Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Milestone Pharmaceuticals: Q1 Earnings Insights

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:16 AM. Here’s what…
byBenzinga Insights
May 11, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:16 AM.

Here’s what investors need to know about the announcement.

Earnings

Milestone Pharmaceuticals beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.

Revenue was up $1.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 1.79% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Deckers Outdoor Shares After Earnings?

By Erica Kollmann
May 24, 11:59 AM
Deckers Outdoor reported quarterly earnings of $4.95 per share which beat the analyst consensus estimate of $2.90 by 70.69%. Quarterly sales also came in above estimates at $959.758 million. Investors appear to be so enamored with the company's quarterly earnings that they are overlooking the company's fiscal year outlook for earnings of between $29.50 and $30.00 per share, slightly below the $30.29 consensus estimate.

DECK